Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two RCTs
Zurich Open Repository and Archive (University of Zurich) · 22.01.2025
DOI: 10.5167/uzh-268929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zurich Open Repository and Archive (University of Zurich), erschienen am 22.01.2025. Verfasst von Slob und 59 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Long‐acting beta2‐agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially due to the presence of the Arg16Gly polymorphism, encoded by rs1042713 G>A in the ADRB2 gene. Carrying the A allele (Arg16) at this variant has been associated with an increased risk of exacerbations despite LABA treatment. We investigated whether genotype‐guided treatment improved asthma‐related outcomes.
Methods
We conducted an individual participant data meta‐analysis of two randomised controlled trials: PUFFIN (Dutch and Swiss 6–18 year‐olds) and PACT (English and Scottish 12–18 year‐olds). Children with uncontrolled asthma despite ICS who required a step‐up in treatment were included. Participants were randomised to genotype‐guided treatment or the control group with a follow‐up of at least 6 months. Genotype‐guided treatment consisted of adding LABA for children with ADRB2 Gly16/Gly16, whilst children with ADRB2 Arg16/Arg16 or Arg16/Gly16 were treated with double dose ICS (PUFFIN) or add‐on montelukast (PACT). The primary outcome was a change in asthma control; secondary outcomes included exacerbation rate and time to exacerbation. Repeated measures mixed models and Cox regression were used.
Results
Fifty‐nine out of 102 (PUFFIN) and 59 out of 91 (PACT) children had at least one Arg (A allele). Amongst all 193 children, no difference was observed in asthma control between the study groups. However, genotype‐guided treatment resulted in lower asthma exacerbation rates (−0.08 (95%CI −0.16 to −0.00, p = 0.04)) compared to the control group.
Conclusion
Genotype‐guided step‐up treatment for children with uncontrolled asthma on ICS may lower asthma exacerbation rates and may be useful for personalising asthma care.
Schlagwörter
Zitieren
APA
Slob, A, E. M., Vijverberg, H, S. J., Ruffles, Tom, Noij, E, L. C., Biermann, Jacqueline, Brouwer, J, A. F., Brink, V. D., Kristel, Bruin‐Kok, D., Annette, Ewijk, V., E, B., Haarman, …, & R, J. W. (2025). Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two RCTs. Zurich Open Repository and Archive (University of Zurich). https://doi.org/10.5167/uzh-268929
Vancouver
Slob, A EM, Vijverberg, H SJ, Ruffles, Tom, et al. Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two RCTs. Zurich Open Repository and Archive (University of Zurich). 2025. doi:10.5167/uzh-268929
BibTeX
@article{Slob2025,
author = {Slob and A, Elise M and Vijverberg and H, Susanne J and Ruffles and Tom and Noij and E, Lieke C and Biermann and Jacqueline and Brouwer and J, Alwin F and Brink, van den and Kristel and Bruin‐Kok, de and Annette and Ewijk, Van and E, Bart and Haarman and Eric and Hammer and C, Sanne and Hashimoto and Simone and Hogarth and Fiona and Jones and J, Christina and Kamps and A, Arvid W and Kersten and G, Elin T and Kleer, de and Ismé and Lipworth and J, Brian and Littleford and Roberta and Mérelle and Marieke and Moeller and Alexander and Palmer and A, Colin N and Pilvinyte and Kristina and Rutjes and W, Niels and Schaik, van and N, Ron H and Smith and E, Helen and Tavendale and Roger and Terheggen‐Lagro and J, Suzanne W and Turner and Steve and Twisk and R, Jos W},
title = {Genotype‐Guided Asthma Treatment Reduces Exacerbations in Children: Meta‐Analysis of Two RCTs},
journal = {Zurich Open Repository and Archive (University of Zurich)},
year = {2025},
doi = {10.5167/uzh-268929}
}
EUVIMED